Amylyx Pharmaceuticals Inc (AMLX)

12:51 PM

Trend Report: Is Amylyx Pharmaceuticals Inc benefiting from interest rate changesWeekly Trade Recap & Community Trade Idea Sharing - baoquankhu1.vn

12:51 PM

Jan 27, 2026

Amylyx Pharmaceuticals: Back From The Dead (NASDAQ:AMLX) - Seeking Alpha

Jan 27, 2026

Jan 27, 2026

FY2030 Earnings Estimate for AMLX Issued By HC Wainwright - MarketBeat

Jan 27, 2026

Jan 25, 2026

Is Amylyx Pharmaceuticals Inc still a buy after recent gainsJuly 2025 Chart Watch & Entry Point Strategy Guides - baoquankhu1.vn

Jan 25, 2026

Jan 25, 2026

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 25, 2026

Jan 24, 2026

Amylyx nominates AMX0318 as long-acting GLP-1 candidate for rare endocrine disorders - MSN

Jan 24, 2026

Jan 22, 2026

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Down 4.5%What's Next? - MarketBeat

Jan 22, 2026

Jan 22, 2026

How Investors May Respond To Gubra (CPSE:GUBRA) Securing Amylyx GLP-1 Milestones And Royalty Upside - Yahoo Finance

Jan 22, 2026

Jan 22, 2026

Amylyx Pharmaceuticals stock hits 52-week high at $16.96 By Investing.com - Investing.com Nigeria

Jan 22, 2026

Jan 22, 2026

Amylyx Pharma Hits New HighDelivers Over 160% Gain In 7 Months - Nasdaq

Jan 22, 2026

Jan 21, 2026

Amylyx Pharmaceuticals (NASDAQ:AMLX) Reaches New 52-Week HighTime to Buy? - MarketBeat

Jan 21, 2026

Jan 21, 2026

January 2027 Options Now Available For Amylyx Pharmaceuticals (AMLX) - Nasdaq

Jan 21, 2026

Jan 21, 2026

Amylyx Pharmaceuticals stock hits 52-week high at $16.96 - Investing.com

Jan 21, 2026

Jan 21, 2026

Amylyx Pharmaceuticals (AMLX) Valuation After AMX0318 Rare Disease Pipeline Update - simplywall.st

Jan 21, 2026

Jan 21, 2026

Amylyx pharma co-CEO Klee sells $1.88 million in AMLX stock - Investing.com Australia

Jan 21, 2026

Jan 20, 2026

Amylyx pharma co-CEO Klee sells $1.88 million in AMLX stock By Investing.com - Investing.com India

Jan 20, 2026

Jan 20, 2026

Amylyx pharma co-CEO Cohen sells $1.87m in shares By Investing.com - Investing.com India

Jan 20, 2026

Jan 20, 2026

Amylyx Pharmaceuticals (NASDAQ:AMLX) CEO Sells $1,850,862.87 in Stock - MarketBeat

Jan 20, 2026

Jan 20, 2026

Amylyx Pharmaceuticals (NASDAQ:AMLX) CEO Sells $27,300.42 in Stock - MarketBeat

Jan 20, 2026

Jan 20, 2026

Amylyx pharma co-CEO Cohen sells $1.87m in shares - Investing.com

Jan 20, 2026

Jan 20, 2026

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading 11.7% HigherHere's What Happened - MarketBeat

Jan 20, 2026

Jan 20, 2026

Amylyx Pharmaceuticals Inc (AMLX) Shares Up 8.85% on Jan 20 - GuruFocus

Jan 20, 2026

Jan 20, 2026

EV Market: Is Amylyx Pharmaceuticals Inc stock a good pick for beginnersWeekly Stock Recap & Pattern Based Trade Signal System - baoquankhu1.vn

Jan 20, 2026

Jan 20, 2026

Amylyx Nominates AMX0318 as Long-Acting GLP-1 Candidate for Rare Endocrine Disorders - Finviz

Jan 20, 2026

Jan 19, 2026

More Money In The Bank For Amylyx Pharmaceuticals Insiders Who Divested US$2.0m - 富途牛牛

Jan 19, 2026

Jan 16, 2026

Amylyx Pharmaceuticals Inc (AMLX) Trading 3.18% Higher on Jan 16 - GuruFocus

Jan 16, 2026

Jan 16, 2026

9 Overlooked Growth Stocks to Buy - Insider Monkey

Jan 16, 2026

Jan 14, 2026

Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Up 6.5%What's Next? - MarketBeat

Jan 14, 2026

Jan 13, 2026

Insider Trends: Will Amylyx Pharmaceuticals Inc. stock sustain high P E ratios2025 Trading Recap & Fast Moving Stock Watchlists - Bộ Nội Vụ

Jan 13, 2026

Jan 11, 2026

Amylyx Pharmaceuticals (AMLX) Valuation Check As New GLP-1 Candidate AMX0318 Enters Development Stage - Yahoo Finance

Jan 11, 2026

Jan 10, 2026

Amylyx Pharmaceuticals (AMLX) announces the selection of AMX0318 as development candidate for PBH and other rare diseases - MSN

Jan 10, 2026

Jan 10, 2026

Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases - Finviz

Jan 10, 2026

Jan 10, 2026

Is Amylyx Pharmaceuticals Inc. stock trading at a premium valuation2025 Technical Overview & Short-Term Trading Alerts - ulpravda.ru

Jan 10, 2026

Jan 09, 2026

Buy Rating on Amylyx: Avexitide’s High Unmet Need, Strong PBH Opportunity, and Clear Phase III Catalyst Support Upside - TipRanks

Jan 09, 2026

Jan 09, 2026

How Amylyx Pharmaceuticals’ (AMLX) Move Into GLP-1 Rare Diseases Has Changed Its Investment Story - Sahm

Jan 09, 2026

Jan 09, 2026

Amylyx selects AMX-0318 as development candidate - BioWorld MedTech

Jan 09, 2026

Jan 09, 2026

Amylyx selects AMX0318 as development candidate for PBH - Yahoo Finance

Jan 09, 2026

Jan 09, 2026

Is Amylyx Pharmaceuticals Inc. stock recession proofJuly 2025 Reactions & Stepwise Entry/Exit Trade Alerts - Улправда

Jan 09, 2026

Jan 08, 2026

Why Amylyx Pharmaceuticals Inc. stock could outperform in 2025Treasury Yields & Community Consensus Stock Picks - Улправда

Jan 08, 2026

Jan 08, 2026

Top Amylyx Executives Quietly Cash Out in Coordinated Stock Moves - TipRanks

Jan 08, 2026

Jan 08, 2026

James Frates Sells 3,326 Shares of Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock - MarketBeat

Jan 08, 2026

Jan 08, 2026

Mizuho reiterates Outperform rating on Amylyx stock, cites GLP-1 program By Investing.com - Investing.com Nigeria

Jan 08, 2026

Jan 08, 2026

Mizuho reiterates Outperform rating on Amylyx stock, cites GLP-1 program - Investing.com Australia

Jan 08, 2026

Jan 08, 2026

US company unveils candidate for Gubra partnership - medwatch.com

Jan 08, 2026